Microgynon

Ethinylestradiol and Levonorgestrel, the active ingredient in Microgynon, is a combined oral contraceptive presented as an oral tablet for oral use. It prevents unintended pregnancy in women of reproductive age and may also help regulate menstrual cycles. The formulation delivers consistent hormone levels throughout the cycle, supporting effective ovulation suppression.

GNH USA supplies Microgynon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, and ensures quality assurance through rigorous testing and regulatory compliance. Our global distribution network enables timely delivery to diverse healthcare settings.

Microgynon, a combined oral contraceptive, acts on the hypothalamic‑pituitary‑ovarian axis to prevent pregnancy.

Contraception: prevents ovulation and pregnancy in women of childbearing age. Menstrual cycle regulation: provides more predictable periods and reduces heavy bleeding. Acne treatment: improves hormonal acne by reducing androgenic activity. Endometriosis symptom relief: alleviates pelvic pain associated with endometriosis. Polycystic ovary syndrome (PCOS) management: helps regulate cycles and reduce androgen levels.